Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis.

Molecular cell | May 14, 2009

http://www.ncbi.nlm.nih.gov/pubmed/19481525

It is intuitively obvious that the ability of a cell to repair DNA damage is saturable, either by limitation of enzymatic activities, the time allotted to achieve their function, or both. However, very little is known regarding the mechanisms that establish such a threshold. Here we demonstrate that the CUL4A ubiquitin ligase restricts the cellular repair capacity by orchestrating the concerted actions of nucleotide excision repair (NER) and the DNA damage-responsive G1/S checkpoint through selective degradation of the DDB2 and XPC DNA damage sensors and the p21/CIP1/WAF1 checkpoint effector. We generated Cul4a conditional knockout mice and observed that skin-specific Cul4a ablation dramatically increased resistance to UV-induced skin carcinogenesis. Our findings reveal that wild-type cells do not operate at their full DNA repair potential, underscore the critical role of CUL4A in establishing the cellular DNA repair threshold, and highlight the potential augmentation of cellular repair proficiency by pharmacological CUL4A inhibition.

Pubmed ID: 19481525 RIS Download

Mesh terms: Animals | Cells, Cultured | Cullin Proteins | Cyclin-Dependent Kinase Inhibitor p21 | DNA Damage | DNA Repair | DNA-Binding Proteins | Fibroblasts | Genes, cdc | Mice | Mice, Knockout | Skin Neoplasms | Transgenes | Ultraviolet Rays

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA098210
  • Agency: NCI NIH HHS, Id: CA118085
  • Agency: NIEHS NIH HHS, Id: ES014482
  • Agency: NCI NIH HHS, Id: R01 CA098210
  • Agency: NCI NIH HHS, Id: R01 CA098210-01A1
  • Agency: NCI NIH HHS, Id: R01 CA098210-02
  • Agency: NCI NIH HHS, Id: R01 CA098210-03
  • Agency: NCI NIH HHS, Id: R01 CA098210-04
  • Agency: NCI NIH HHS, Id: R01 CA098210-05
  • Agency: NCI NIH HHS, Id: R01 CA098210-06A1
  • Agency: NCI NIH HHS, Id: R01 CA118085
  • Agency: NCI NIH HHS, Id: R01 CA118085-01
  • Agency: NCI NIH HHS, Id: R01 CA118085-02
  • Agency: NCI NIH HHS, Id: R01 CA118085-03
  • Agency: NCI NIH HHS, Id: R01 CA118085-04
  • Agency: NIEHS NIH HHS, Id: R01 ES014482
  • Agency: NIEHS NIH HHS, Id: R01 ES014482-04
  • Agency: NCI NIH HHS, Id: R56 CA098210
  • Agency: NCI NIH HHS, Id: R56 CA098210-06

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.